drugset / Trial / NCT01874860
Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if using preventive treatments such as Doxycycline (an anti-biotic) capsules, sunscreen with SPF 30, Hydrocortisone 1% cream and a moisturizer will help to reduce the incidence and severity of the skin rash associated with Cetuximab (Erbitux®) when compared to receiving standard care for the treatment of skin rash.
Timeline
- Start
- 2013-08
- Primary completion
- 2018-07
- Completion
- 2018-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doxycycline | Small molecule | 100 mg | — |
| Subject | Hydrocortisone 1% cream | Unknown | 1 % | — |
| Background | Clindamycin | Unknown | 1 % | — |
| Background | Methylprednisolone | Other / unclassified | — | — |